Sativex achieved sustained
improvements in spasticity vs
placebo when used as an adjunct1

Patients who
respond to
Sativex can have
significant
reductions in
spasticity
severity vs
placebo1,2

Symptom
improvement
Image
icons

Sativex achieved sustained improvements in spasticity vs placebo when used as an adjunct to existing treatment1

Mean NRS scores during single-blind and double-blind randomised treatment phases1

Image
graph
Image
graph-mobile

Adding Sativex to existing treatment can improve a wide range of patients’ spasticity-related symptoms3

Spasticity-related symptoms reported as improved from baseline by patients3

Image
graph
Image
graph-mobile

17.0% of patients had improvements in 2 symptoms, and 16.7% had improvements in ≥3 symptoms from baseline (N=1,615)*3